Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. (Q44866619)
Jump to navigation
Jump to search
scientific article published in May 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. |
scientific article published in May 2004 |
Statements
1 reference
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. (English)
1 reference
Jack W Coburn
1 reference
Hla M Maung
1 reference
Logan Elangovan
1 reference
Michael J Germain
1 reference
Jill S Lindberg
1 reference
Stuart M Sprague
1 reference
Mark E Williams
1 reference
Charles W Bishop
1 reference
1 reference
Identifiers
1 reference